European Union Approves Giotrif (Afatinib) for Lung Squamous Cell Carcinoma
Lung Cancer, News
The European Union (EU) approved Giotrif (afatinib) on April 8 for the treatment of advanced squamous cell carcinoma (SqCC) of the lung in people for whom the disease has progressed despite treatment ... Read more